Hannah Norman, Kaiser Health News
Quick Covid tests at home are flying off store shelves across the country and are being sold online to complicate Delta alternative school, work and travel routines.
But in a test of $ 10 or $ 15, the price for regular use by anyone other than the rich is still much higher. One family of two school-age children may have to spend $ 500 or more a month trying to keep their family এবং and others নিরাপ safe.
For Americans looking for a quick answer, the cheapest over-the-counter covid test is the Abbott Laboratories Binaxnow Two-Pack at 23.99. Quidditch QuickView test on the back, প 15 a pop. Yet supply is declining. Following the demand, CVS is limiting the number of tests people can buy, and Amazon and Walgreen’s websites are on sale until Friday afternoon.
President Joe Biden said Thursday that he would call for defense production legislation to make 280 million faster Covid tests available. The administration has entered into agreements with Walmart, Amazon and Kroger to sell the test “35 percent less than the current retail price” for three months. Biden said those who are on Medicaid will have their home tests completely covered.
An increased supply will help reduce prices. Since schools are open and most parts of the country have faded without epidemic-related restrictions, epidemiologists say extensive rapid screening, including vaccinations and masks, is important to control the spread of the delta variant. Yet deficits, little competition, and sticky high prices mean routine quick tests are beyond the reach of most Americans, even if prices drop by 35%.
Elsewhere consumers have many cheap – or free options. In Germany, grocery stores are selling Covid tests quickly below $ 1 per test. In India, they cost around $ 3.50. The UK offers 14 free tests per person. Free Quick Testing for Canada Business.
Harvard University Assistant Professor of Epidemiology Michael Mina praises Biden’s announcement On Twitter When he said “some reservations” about his scale and mentioned that 280 million tests represented “less than one test per person per year”.
Representative Kim Shreer (D-Wash.) Has suggested rapid testing at low cost for several months. In the days leading up to Biden’s announcement, he said, “In an ideal world, a test would be either free or less than a dollar so people could take it several times a day every day.”
Biden’s initiative for greater rapid testing is “a great start,” Shriya said Friday. “But there is much more to be done to use this really important tool to deal with this virus, and it needs to be done quickly.”
A nationwide survey published in February by the Harvard TH Chan School of Public Health and Heart Research found that 79% of adults would test themselves regularly at home if it cost a dollar for a quick test. But if the cost is $ 25, only one-third will do so.
Billions of dollars have been invested in these products. Abbott Laboratories, for example, has cashed in millions of federal contracts and paid large sums of money to its shareholders last year, with quarterly dividends rising 25%. Yet, according to an investigation in the New York Times, for the need to test quickly in early summer, Abbott destroyed his supplies and laid off the workers who were making them.
More than a year ago, Abbott said the company would sell its BinaxNow to healthcare providers for as much as 5, but that option is not available to the public over the counter. Even with the expected price reduction, a two-pack will cost more than $ 15. Abbott did not comment further.
Shriya said in the spring that the cost of testing was high because “big companies are buying all supplies.” Also, “their profit is much more than 30,000 $ 1 test to 1,000 $ 30 test” – in other words, they can earn the same amount for much less test.
In March, the Biden administration allocated 10 10 billion to test Covid in schools as part of the American Rescue Plan Act, which leaves the rollout in most states. The Trump administration then bought Abbott’s 150 million Rapid Response Antigen Test at a cost of ০ 100 million, many of which went to school. The rollout has been mixed, with states like Missouri facing logistical challenges.
In late August, Shriya wrote a letter to four federal agencies to update their distribution plans. He called on the government to increase spending on exams quickly, saying “time is of the essence” as children return to school.
Antigen tests can provide real-time information to people who come in contact with Covid, said Dr. Columbia, an associate professor of emergency medicine at Columbia University Medical Center. Dara Kas. It may take a few days to wait for lab results from the Polymerase Chain Reaction (PCR) test, and many states বিশেষ especially hard-hitting South দেখ are looking to fill appointments a few days in advance. Home collection kits for PCR testing can cost upwards of $ 100.
Quick testing takes less than 15 minutes to detect covids by identifying proteins called antigens. The tests are similar to the pregnancy test, depending on the result one or two lines are displayed.
The Centers for Disease Control and Prevention recommends that fully vaccinated people who come in contact with Kovid wear a mask indoors for two weeks and be tested three to five days after exposure. Obsolete ones should be segregated for 14 days. But it leaves a gray area for those vaccinated who hope to join the class or make a living, Cass said.
“Quick testing gives information,” he adds, “it allows someone to safely join society.” People can follow PCR tests to confirm the diagnosis, which is more sensitive.
In Massachusetts, for example, a “test and stay” strategy for students who come in contact with Covid allows them to stay in school: after close contact with an infected person, students also take the Benacon test for five consecutive days.
More than 0 antigen tests have been developed in the United States যদিও although only six companies have FDA approval for over-the-counter use. There is no complete FDA approval for any rapid covid test. The two fast molecular alternatives, created by Lucira Health and Q Health, also have Emergency Use Approval (EUA).
“Unfortunately, many submissions are incomplete or there is insufficient information for the FDA to meet the statutory criteria,” said FDA spokesman James McKinney.
The company has taken a tougher stance than its European counterparts. In June, the FDA warned Americans to stop using Innova Medical Group’s rapid antigen test, saying the agency had “significant concerns that the effectiveness of the test was not adequately established.” Yet in the UK, which has a multi-billion dollar deal with a California company, the regulator has fixed the product.
In Germany, regulators have given special approval to dozens of antigen tests.
“Unless these tests are regulated as medical devices, the FDA should regulate them not as critical public health equipment, but as medical equipment, all difficult clinical trials that make everything 100 times slower,” Mina said. Said on Twitter.
Because of just a few quick tests in the market, it’s hard for companies that haven’t received FDA approval and instead to lower prices, says Michael Greeley, co-founder and general partner at Flyer Capital Partners, a venture capital firm focused on healthcare technology. “If we talk about people checking their kids to go to school every day,” he added, “for many families, the current costs are a real burden.”
The rapid adoption of rapid testing seems premature, he said, even with massive purchases by the U.S. government: “We can’t even floss people, so the idea that people are now starting to test quickly as their standard operating system is a flawed assumption. “
Regardless, companies cannot keep up with demand.
Elum said it increased its test usage by 900% last month. Its in-house quick test costs up to $ 38.99. On Walmart’s website, it was listed at 26 26.10 on Friday but was out of stock.
The Australian manufacturer received 232 million from the U.S. Department of Defense in February after the FDA approved its home use late last year. But the Federal Health Care Enhancement Act, which provided the funding, does not impose price restrictions. Elum said it will begin production of a Frederick in Maryland this fall. For now, it’s testing shipping from Australia.
This summer, Lucira Health stopped selling its nearly 50 50 nuclear rapid test online to focus on larger clients, including the San Francisco Chase Center, the Golden State Warriors home and the Olympics, Lucira’s chief financial officer Dan George said during a recent earnings call.
The company is still losing money because it has increased production but expects to sell directly on its website and Amazon later this year.
KHN (Kaiser Health News) is a national newsroom that creates in-depth journalism on health issues. Along with policy analysis and polling, KHN is one of the three main operating programs of KFF (Kaiser Family Foundation). KFF is a rich non-profit organization that provides health information to the nation.
Use our content
This story can be republished for free (details).